STOCK TITAN

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

OPKO Health (NASDAQ: OPK) has announced it will release its second quarter 2024 financial results on August 7, 2024, after the U.S. financial markets close. The company will host a conference call and live audio webcast at 4:30 p.m. Eastern time on the same day to discuss the results and provide a business update. Senior management will also offer financial guidance during the call.

Participants are encouraged to pre-register for the conference call using a provided link. Those unable to pre-register can dial in using specific numbers for U.S. and International callers. A webcast of the call will be accessible through OPKO's Investor Relations page. Both telephone and webcast replays will be available for a time after the call.

Loading...
Loading translation...

Positive

  • OPKO Health is providing forward-looking financial guidance, which may indicate confidence in their future performance
  • The company is maintaining transparent communication with investors through a scheduled earnings call and webcast

Negative

  • None.

News Market Reaction 1 Alert

-1.82% News Effect

On the day this news was published, OPK declined 1.82%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Wednesday, August 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on August 7th beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available through August 14, 2024 by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 6314261. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com


FAQ

When will OPKO Health (OPK) report its Q2 2024 financial results?

OPKO Health (OPK) will report its second quarter 2024 financial results on August 7, 2024, after the close of U.S. financial markets.

What time is OPKO Health's (OPK) Q2 2024 earnings conference call?

OPKO Health's (OPK) Q2 2024 earnings conference call is scheduled for August 7, 2024, at 4:30 p.m. Eastern time.

How can investors participate in OPKO Health's (OPK) Q2 2024 earnings call?

Investors can pre-register for the call using a provided link or dial in directly. U.S. callers can use 833-630-0584, while international callers should use 412-317-1815.

Will OPKO Health (OPK) provide financial guidance during its Q2 2024 earnings call?

Yes, OPKO Health's senior management will provide financial guidance during the Q2 2024 earnings call on August 7, 2024.
Opko Health

NASDAQ:OPK

OPK Rankings

OPK Latest News

OPK Latest SEC Filings

OPK Stock Data

982.66M
393.77M
46.77%
26.32%
4.09%
Diagnostics & Research
Pharmaceutical Preparations
Link
United States
MIAMI